Roche Diabetes Care glucose test strips may falsely report elevated blood glucose levels, prompting the FDA to slap the devices with Class 1 recall status, the most serious type of recall that involves situations with a reasonable probability that continued use will cause serious injury or death.

The Roche strips were distributed in France in October 2010 and were never distributed in the U.S.

Roche Diabetes Care’s Insulin Delivery Systems unit issued a recall for one of its infusion sets while it tries to work out the kinks — literally.

There’s a possibility that its Accu-Chek FlexLink Plus will under-deliver insulin because the tube that delivers the medication, the cannula, can become kinked, according to the company.